Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.38 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Disodium Laureth Sulfosucccinate SCHEMBL27916855 | 1.00 | NAAA (0.41) | NAAADGKARECQLMAPK1CES2 | |
| SCHEMBL25166910 | 0.92 | NAAA (0.49) | NAAADGKARECQLMAPK1GLA | |
| SCHEMBL30081498 | 0.92 | NAAA (0.49) | NAAADGKARECQLMAPK1GLA | |
| SCHEMBL671816 | 0.86 | RECQL (0.44) | RECQLMAPK1CES2GLAHPGD | |
| SCHEMBL8902267 | 0.83 | ALDH1A1 (0.40) | RECQLMAPK1CES2GLAHPGD | |
| SCHEMBL5075106 | 0.82 | NAAA (0.50) | NAAADGKARECQLMAPK1GLA | |
| SCHEMBL283124 | 0.82 | NAAA (0.50) | NAAADGKARECQLMAPK1GLA | |
| SCHEMBL22809 | 0.82 | NAAA (0.50) | NAAADGKARECQLMAPK1GLA | |
| SCHEMBL219917 | 0.82 | NAAA (0.50) | NAAADGKARECQLMAPK1GLA | |
| SCHEMBL1282784 | 0.82 | NAAA (0.50) | NAAADGKARECQLMAPK1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2395966-B1 | COSMETIC COMPOSITION FOR SKIN CARE | LENGHEIM HUBERT (AT) | 2016-07-06 | — | — | EP | claimed |
| WO-2010091827-A2 | COSMETIC FORMULATION FOR SKIN CARE | LENGHEIM HUBERT (AT) | 2010-08-19 | — | — | WO | claimed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4186969-B1 | SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION | HENKEL AG & CO KGAA (DE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4687810-A1 | PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE | Symrise AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | disclosed |
| WO-2010091827-A2 | COSMETIC FORMULATION FOR SKIN CARE | LENGHEIM HUBERT (AT) | 2010-08-19 | — | — | WO | disclosed |
| EP-1465491-B1 | ANTISEPTIC COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2009-01-21 | — | — | EP | disclosed |
| EP-1955594-A1 | Antiseptic compositions and methods | 3M Innovative Properties Company (US) | 2008-08-13 | — | — | EP | disclosed |
| US-7323163-B2 | Film-forming compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-01-29 | — | — | US | disclosed |
| EP-1849487-A2 | Film-forming compositions and methods | 3M Innovative Properties Company (US) | 2007-10-31 | — | — | EP | disclosed |
| EP-1465676-B1 | FILM-FORMING COMPOSITIONS AND THEIR USES | 3M INNOVATIVE PROPERTIES CO (US) | 2007-08-15 | — | — | EP | disclosed |
| US-7147873-B2 | I2 and/or an iodophor to provide an available iodine concentration of at least 0.25 wt-%; a hydroxycarboxylic acid buffer; water; and a substantive film-forming polymer. | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-12-12 | — | — | US | disclosed |
| US-20050025794-A1 | Film-forming compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-02-03 | — | — | US | disclosed |
| US-6838078-B2 | Film-forming compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | THRB 1828/4885CA2 4525/4885NAAA 1798/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | THRB 82/4885CA2 1876/4885NAAA 3100/4885 |
| US-20050025794-A1 | Film-forming compositions and methods | VCL, PUF60, PHOSPHO1 | THRB 4445/4885CA2 4036/4885NAAA 67/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | THRB 2049/4885CA2 332/4885NAAA 2012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.